Who travels for stem cell therapy — and why

Searches for "stem cell abroad" have tripled since 2023, driven by orthopaedic and neurological cases, with savings of 40–80%. Relative demand by source market:

Relative demand index by source market

United States90

United Kingdom78

Gulf (UAE/KSA/Qatar)70

Germany62

Canada55

Israel40

Scandinavia/NL35

China/East Asia48

Why they travel

USA — most therapies remain experimental under the FDA; patients save 40–80%.
UK — limited availability and long private waits.
Gulf — high willingness to pay, family-led care, fast medical visas.
Germany — same EU quality at home costs €15–35k; Bulgaria is the price-shock alternative.

Relative index (illustrative), based on 2025–26 medical-tourism reporting.

Zelltherapie auf EU-Niveau – ohne westeuropäische Preise.

GMP-zertifizierte regenerative Medizin mitten in der EU — ab 3.000–8.000 €, ein Bruchteil der US- oder Deutschland-Preise. Individuelle Protokolle für internationale Patienten aus über 50 Ländern.

Kostenlose ärztliche Prüfung

Who travels for stem cell therapy — and why

Why they travel

For these patients

Zelltherapie auf EU-Niveau – ohne westeuropäische Preise.